Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ribonucleotide reductase M1 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 8 uM | Inhibitory concentration against HSV-1 ribonucleotide reductase R1 protein binding | ChEMBL. | 1310120 |
IC50 (binding) | = 8 uM | Inhibitory concentration against HSV-1 ribonucleotide reductase R1 protein binding | ChEMBL. | 1310120 |
Inhibition (binding) | = 33 % | Inhibitory concentration against HSV-1 ribonucleotide reductase R1 protein binding relative to Ac-VZV R2-(298-306) | ChEMBL. | 1310120 |
Inhibition (binding) | = 33 % | Inhibitory concentration against HSV-1 ribonucleotide reductase R1 protein binding relative to Ac-VZV R2-(298-306) | ChEMBL. | 1310120 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.